Insulin-like growth factor-I, insulin, and angina pectoris secondary to coronary atherosclerosis, vasospasm, and syndrome X.
We measured growth hormone-related substances in patients with angina pectoris precipitated by different underlying disorders. Although hyperinsulinemia was more pronounced in patients with angina pectoris secondary to atherosclerotic coronary disease than in patients with syndrome X and variant angina, we found no evidence that growth hormone-related substances including insulin-like growth factor-I are associated with coronary atherosclerosis.
Bøtker
H E
HE
Department of Cardiology, Skejby Hospital, University Hospital in Aarhus, Denmark.
Skjaerbaek
C
C
Eriksen
U H
UH
Schmitz
O
O
Orskov
H
H
D000787:Angina Pectoris / Q000097:blood* / Q000209:etiology*; D000788:Angina Pectoris, Variant / Q000097:blood / Q000150:complications*; D003324:Coronary Artery Disease / Q000097:blood / Q000150:complications*; D005260:Female; D019382:Human Growth Hormone / Q000097:blood; D006801:Humans; D007328:Insulin / Q000097:blood*; D007333:Insulin Resistance; D007334:Insulin-Like Growth Factor I / Q000032:analysis*; D008297:Male; D017566:Microvascular Angina / Q000097:blood / Q000150:complications*; D008875:Middle Aged
D007328:Insulin; D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I